These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21310066)

  • 1. Overexpression of Sterol Carrier Protein 2 in patients with hereditary cholesterol gallstones.
    Cui Y; Li Z; Zhao E; Jia Y; Li D; Zhang J; Cui N
    BMC Gastroenterol; 2011 Feb; 11():10. PubMed ID: 21310066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of sterol carrier protein-2 mRNA in patients with cholesterol gallstones.
    Cui NQ; Zhang SK; Cui YF; Li DH; Chen C; Wu XZ
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):117-20. PubMed ID: 15730934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice.
    Fuchs M; Lammert F; Wang DQ; Paigen B; Carey MC; Cohen DE
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):33-7. PubMed ID: 9806881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism.
    Fuchs M; Hafer A; Münch C; Kannenberg F; Teichmann S; Scheibner J; Stange EF; Seedorf U
    J Biol Chem; 2001 Dec; 276(51):48058-65. PubMed ID: 11673458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models.
    Cui Y; Li Z; Zhao E; Zhang J; Cui N
    EXCLI J; 2012; 11():593-603. PubMed ID: 27847447
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased bile lithogenicity by SCP2 via HMGCR and CYP7A1 regulation in human hepatocytes.
    Yunfeng C; Zhonglian L; Erpeng Z; Ju Z; Naiqiang C
    Turk J Gastroenterol; 2013; 24(3):241-50. PubMed ID: 24226717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
    Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
    Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.
    Fuchs M; Ivandic B; Müller O; Schalla C; Scheibner J; Bartsch P; Stange EF
    Hepatology; 2001 Jun; 33(6):1451-9. PubMed ID: 11391534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
    Xu G; Zhao L; Fuchs M
    Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U; Sahlin S; Einarsson C
    Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients.
    Jiang ZY; Parini P; Eggertsen G; Davis MA; Hu H; Suo GJ; Zhang SD; Rudel LL; Han TQ; Einarsson C
    J Lipid Res; 2008 Feb; 49(2):464-72. PubMed ID: 18007013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
    Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
    Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling plasma lipoprotein-bile lipid relationships: differential impact of psyllium and cholestyramine in hamsters fed a lithogenic diet.
    Trautwein EA; Siddiqui A; Hayes KC
    Metabolism; 1993 Dec; 42(12):1531-40. PubMed ID: 8246766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice.
    Wang DQ
    J Lipid Res; 2002 Nov; 43(11):1950-9. PubMed ID: 12401894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterol Carrier Protein-2, a Nonspecific Lipid-Transfer Protein, in Intracellular Cholesterol Trafficking in Testicular Leydig Cells.
    Li NC; Fan J; Papadopoulos V
    PLoS One; 2016; 11(2):e0149728. PubMed ID: 26901662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reabsorption of bile acids regulated by FXR-OATP1A2 is the main factor for the formation of cholesterol gallstone.
    Cai J; Wang Z; Chen G; Li D; Liu J; Hu H; Qin J
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G303-G308. PubMed ID: 32597704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
    Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
    Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular cholesterol transport proteins enhance hydrolysis of HDL-CEs and facilitate elimination of cholesterol into bile.
    Wang J; Bie J; Ghosh S
    J Lipid Res; 2016 Sep; 57(9):1712-9. PubMed ID: 27381048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.
    Holan KR; Holzbach RT; Hermann RE; Cooperman AM; Claffey WJ
    Gastroenterology; 1979 Oct; 77(4 Pt 1):611-7. PubMed ID: 467918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice.
    He H; Wang J; Yannie PJ; Kakiyama G; Korzun WJ; Ghosh S
    J Biol Chem; 2018 Jun; 293(24):9223-9231. PubMed ID: 29700117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.